Skip to content

China multi-center Cohort study On Risk Evaluation of Arrhythmogenic CardioMyopathy

Risk stratification study on patients with arrhythmogenic cardiomyopathy based on multimodal data - ChinaCORE ACM

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098971
Enrollment
Unknown
Registered
2025-03-17
Start date
2024-06-21
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmogenic Cardiomyopathy

Interventions

Arrhythmogenic Cardiomyopathy:NA

Sponsors

Fuwai Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients who meet with the definite or borderline diagnosis of arrhythmogenic cardiomyopathy based on 2010 modified Task Force Criteria (score calculated according to Task Force Criteria, 2 scores for each major criterion and 1 score for each minor criterion; patients with score = 3 were included).

Exclusion criteria

Exclusion criteria: 1) Previous history of myocardial infarction; 2) Complicated with other structural cardiac diseases, including congenital heart disease (left-to-right shunt, Ebstein malformation), severe rheumatic or senile primary valvular diseases; 3) Complicated with malignant tumors or severe infection, hepatic or renal dysfunction

Design outcomes

Primary

MeasureTime frame
Time from enrollment to fatal heart failure events, including death due to heart failure, heart transplantation and inclusion to waiting list of heart transplantation;

Secondary

MeasureTime frame
Time from enrollment to hospitalization due to worsening of heart failure ;Time from enrollment to adverse ventricular arrhythmia event;

Countries

China

Contacts

Public ContactLiang Chen

Fuwai Hospital, Chinese Academy of Medical Sciences

chenliang_2012@126.com+86 188 0016 1266

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026